STS Summer Series: Clinical Research in VHD during COVID: Adapting to a Dynamic and Multifaceted Pandemic

STS/ACC TVT Registry leaders—Vinod H. Thourani, MD, and John D. Carroll, MD—moderate a panel of investigators, representatives from the Food and Drug Administration (FDA), and industry about valvular heart disease clinical research during COVID. They discuss the effects of the pandemic on research infrastructure, impediments to patient follow-ups and data collection, potential shifts in collaborative trial development guided by the FDA, and new techniques in post-market surveillance. Panelists include Dominic J. Allocco, MD, Andrew Farb, MD, Susheel K. Kodali, MD, Michael J. Mack, MD, Mark Reisman, MD, Barathi Sethuraman, PhD, Changfu Wu, PhD, Bram D. Zuckerman, MD.